Key result
Captopril maintained baseline asymmetric neuro-visceral correlations while reducing blood pressure, whereas L-NAME exacerbated hypertension and completely inverted the right and left frontal cortex correlations with the HPA axis.
Why the study?
The neuro-visceral integration involving aminopeptidase activities in the frontal cortex and HPA axis is asymmetric, dynamic, and modifiable by pathophysiological influences such as hypertension and treatment.
Answers are grounded in this paper and cite their sources.
Treatment with the hypotensive agent captopril promotes a better balance of neuro-visceral angiotensinase interactions in spontaneously hypertensive rats, while the hypertensive agent L-NAME disrupts this balance.
It has been suggested that the neuro-visceral integration works asymmetrically and that this asymmetry is dynamic and modifiable by physio-pathological influences. Aminopeptidases of the renin-angiotensin system (angiotensinases) have been shown to be modifiable under such conditions. This article analyzes the interactions of these angiotensinases between the left or right frontal cortex (FC) and the same enzymes in the hypothalamus (HT), pituitary (PT), adrenal (AD) axis (HPA) in control spontaneously hypertensive rats (SHR), in SHR treated with a hypotensive agent in the form of captopril (an angiotensin-converting enzyme inhibitor), and in SHR treated with a hypertensive agent in the form of the L-Arginine hypertensive analogue L-NG-Nitroarginine Methyl Ester (L-NAME). In the control SHR, there were significant negative correlations between the right FC with HPA and positive correlations between the left FC and HPA. In the captopril group, the predominance of negative correlations between the right FC and HPA and positive correlations between the HPA and left FC was maintained. In the L-NAME group, a radical change in all types of interactions was observed; particularly, there was an inversion in the predominance of negative correlations between the HPA and left FC. These results indicated a better balance of neuro-visceral interactions after captopril treatment and an increase in these interactions in the hypertensive animals, especially in those treated with L-NAME.
No takes yet. Share an insight, caveat, or question.
Prieto et al. (2023) studied Hypertension (in spontaneously hypertensive rats) (n=24). Captopril and L-NAME vs. Control (untreated spontaneously hypertensive rats) was evaluated on Correlation of aminopeptidase activities between the left/right frontal cortex and the hypothalamus-pituitary-adrenal (HPA) axis. Captopril maintained baseline asymmetric neuro-visceral correlations while reducing blood pressure, whereas L-NAME exacerbated hypertension and completely inverted the right and left frontal cortex correlations with the HPA axis.
Synapse has enriched 10 related papers. Consider them for comparative context: